Page last updated: 2024-09-05

sorafenib and Brain Damage, Chronic

sorafenib has been researched along with Brain Damage, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, G; Li, H; Wang, Z; Xu, X; You, W; Zhang, J; Zhou, D1

Other Studies

1 other study(ies) available for sorafenib and Brain Damage, Chronic

ArticleYear
Possible Role of Raf-1 Kinase in the Development of Cerebral Vasospasm and Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats.
    Molecular neurobiology, 2015, Volume: 52, Issue:3

    Topics: Animals; Basilar Artery; Blood-Brain Barrier; Brain Damage, Chronic; Brain Edema; Cyclooxygenase 2; Disease Models, Animal; Down-Regulation; Interleukin-1beta; Interleukin-6; Male; MAP Kinase Kinase Kinases; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase Kinases; Nerve Tissue Proteins; NF-kappa B; Niacinamide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-raf; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Sorafenib; Subarachnoid Hemorrhage; Vascular Endothelial Growth Factor A; Vasospasm, Intracranial

2015